Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Tugçe Yigenoglu and Burhan Turgut.
Tugçe Yigenoglu
Connection Strength
1.262
Burhan Turgut
  1. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci. 2021 Dec; 60(6):103237.
    View in: PubMed
    Score: 0.241
  2. The outcome ofancy. COVID-19 in patients with hematological malign J Med Virol. 2021 03; 93(3):1255.
    View in: PubMed
    Score: 0.228
  3. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2021 02; 93(2):1099-1104.
    View in: PubMed
    Score: 0.225
  4. Convalescent plasma therapy in patients with COVID-19. J Clin Apher. 2020 Aug; 35(4):367-373.
    View in: PubMed
    Score: 0.223
  5. COVID-19 clinical course and blood groups: Turkish population-based study Turk J Med Sci. 2021 08 30; 51(4):1659-1664.
    View in: PubMed
    Score: 0.060
  6. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2022 01; 17(1):135-139.
    View in: PubMed
    Score: 0.059
  7. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 02; 60(1):103017.
    View in: PubMed
    Score: 0.057
  8. COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2021 04; 56(4):952-955.
    View in: PubMed
    Score: 0.057
  9. Convalescent plasma therapy in patients with COVID-19. Transfus Apher Sci. 2021 Feb; 60(1):102955.
    View in: PubMed
    Score: 0.056
  10. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Oct; 26(7):1676-1682.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.